glp-1 cgm and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal? Will GLP-1 medications affect the

Together, these findings provide further evidence of the direct actions of GLP-1RAs on the CNS and PNS

You may be a candidate if you have a BMI of 27 or higher with a weight-related health condition (or 30 or higher without one), have tried diet and exercise without desired results, prefer a non-surgical option, and are committed to lifestyle changes

Incorporate it into your diet through a variety of healthy foods or consider adding a supplement like whey protein

These events are as follows: cardiomyopathy, mydriasis, diplopia, difficulties with visual accommodation, blurred vision, eosinophilic hepatitis, anaphylactic reaction, hypersensitivity, dyskinesia, dysgeusia, motor and verbal tics, bruxism, depression, dermatillomania, alopecia, aggression, Stevens-Johnson Syndrome, chest pain, angioedema, urticaria, seizures, libido changes, frequent or prolonged erections, constipation, rhabdomyolysis, and intestinal ischemia